The Institute for Health Economics (IHE) is conducting an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This policy roundtable will seek to gain multi-stakeholder consensus on policy recommendations intended to optimize care for PF-ILD patients Key areas for discuss are in the following three areas: Multi-disciplinary…
The IHE Life Sciences Commercialization Program supports Alberta, Saskatchewan, Manitoba and British Columbia-based life sciences companies with promising, market-ready healthcare technology that are currently seeking procurement in Canadian or international markets. Support includes the development of an economic model to quantify the technology value…
News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected].
For media inquiries, please contact John Sproule, Senior Policy Director at [email protected]
The IHE has a dedicated Life Sciences SME Platform within the Institute that collaborates with and provides support for SMEs in the life sciences. The IHE provides services to: educate SMEs and support organizations (e.g., accelerators) on the value and use of health economics to support decisions along the commercialization journey as well as procurement efforts; provide early-stage…